In fact, there is a slight trend towards improved survival in the COVID era, with a median OS of 16 months vs. 13 months in the pre-COVID era.
← all excerpts
Treatment Patterns and Outcomes of Patients with Grade 4 Glioma Treated with Radiation during the COVID-19 Pandemic.
1
—
—